Herbas VPB

Print
EN | LT
LT - DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS
EN - DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/18 (2006.01)
C07K 16/18 (2013.01)
C07K 16/40 (2006.01)
C07K 16/40 (2013.01)
A61K 39/395 (2006.01)
C07K2317/24 (2013.01)
A61P 7/00 (2006.01)
C07K2317/76 (2013.01)
C07K2317/94 (2013.01)
A61K2039/505 (2013.01)
A61K2039/54 (2013.01)
A61K2039/545 (2013.01)
A61P 7/00 (2018.01)
European patent
(11) Number of the document 3802593
(13) Kind of document T
(96) European patent application number 19731444.6
Date of filing the European patent application 2019-05-29
(97) Date of publication of the European application 2021-04-14
(45) Date of publication and mention of the grant of the patent 2024-09-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2019/034293
Date 2019-05-29
PCT application publication
(87) Number WO 2019/231983
Date 2019-12-05
Priority applications
(30) Number Date Country code
201862678455 P 2018-05-31 US
Inventors
(72)
PAYTON, Lori , US
ROTTINGHAUS, Scott T. , US
PRADHAN, Rajendra , US
ORTIZ, Stephan , US
OGAWA, Masayo , US
GAO, Xiang , US
Grantee
(73) Alexion Pharmaceuticals, Inc. , 121 Seaport Boulevard, Boston, MA 02210, US
Title
(54) DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS
  DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS